MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/jaha.126.049283

Медицинская библиотека · Journal of the American Heart Association · 2026

Validation of an Artificial Intelligence-Derived ECG Algorithm for Detecting Cardiac Amyloidosis in Patients With Heart Failure With Preserved Ejection Fraction: Clinical Application and Prognostic Implications.

Gioia Guglielmo, Seirer Benjamin, Dusik Fabian, Rettl René, Binder Christina, Duca Franz, Dalos Daniel, Badr-Eslam Roza, Kastner Johannes, Thiele Holger, Hengstenberg Christian, Bonderman Diana, Schrutka Lore

СтатьяВалидационное исследованиеМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Cardiac transthyretin amyloidosis (ATTR-CA) is frequently underdiagnosed and commonly presents as heart failure with preserved ejection fraction (HFpEF). Early identification enables disease-modifying therapy but remains challenging in routine practice, so simple, widely available screening tools are needed.

METHODS

In this multicenter validation study, 885 patients with HF from 2 European centers were included. The internal validation cohort comprised 560 patients with preserved ejection fraction and analyzable ECGs: 149 with ATTR-CA, 318 with HFpEF, and 93 with hypertrophic cardiomyopathy. External validation used an independent cohort of 107 patients (72 ATTR-CA, 31 HFpEF, 4 hypertrophic cardiomyopathy). Standard 12-lead ECGs were analyzed blindly by 3 independent observers using a previously developed, 2-step, artificial intelligence-derived, visually interpretable ECG algorithm.

RESULTS

The ECG pattern was present in 82.6% of patients with ATTR-CA, versus 10.2% with HFpEF and 6.5% with hypertrophic cardiomyopathy (P<0.001). Internal-cohort accuracy was high: area under the curve 0.87 (95% CI, 0.84-0.90), sensitivity 83% (95% CI, 76%-88%), specificity 91% (95% CI, 88%-93%), and negative predictive value 93% (95% CI, 91%-96%). In the external cohort, the area under the curve was 0.84 (95% CI, 0.76-0.92), with sensitivity 89% (95% CI, 78%-94%) and specificity 79% (95% CI, 63%-90%). The pattern was strongly associated with ATTR-CA (odds ratio, 46 [95% CI, 27-80]; P<0.001) and with reduced 3-year survival (log-rank P=0.007).

CONCLUSIONS

A visually interpretable, artificial intelligence-derived ECG algorithm enables effective screening for ATTR-CA among patients with HFpEF. Its simplicity and compatibility with standard ECG systems support broad clinical implementation.

Для цитирования: Gioia Guglielmo, Seirer Benjamin, Dusik Fabian, Rettl René, Binder Christina, Duca Franz, Dalos Daniel, Badr-Eslam Roza, Kastner Johannes, Thiele Holger, Hengstenberg Christian, Bonderman Diana, Schrutka Lore. Validation of an Artificial Intelligence-Derived ECG Algorithm for Detecting Cardiac Amyloidosis in Patients With Heart Failure With Preserved Ejection Fraction: Clinical Application and Prognostic Implications.. Journal of the American Heart Association. 2026. DOI: 10.1161/jaha.126.049283.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.